Literature DB >> 8420337

Hemodynamic and fluid responses to furosemide infusion in the ovine fetus.

T F Kelly1, T R Moore, R A Brace.   

Abstract

OBJECTIVES: The direct effects of furosemide infusion have not been systematically examined in the fetus. Our objective was to explore the hemodynamic and urinary responses to a 4-hour infusion of furosemide into fetal sheep. STUDY
DESIGN: Furosemide (0, 1, 5, or 10 mg/hr) was infused into the fetal inferior vena cava for 4 hours in 15 chronically catheterized near-term sheep.
RESULTS: Relative to vehicle infusion, furosemide produced dose-dependent increases in fetal arterial pressure (analysis of variance, p < 0.05 when comparing groups), fetal heart rate (p < 0.0001), urine flow (p < 0.0001), and urine osmolality, sodium, and chloride, concentrations (p < 0.0001). Concomitantly, there were dose-dependent decreases in fetoplacental blood volume, fetal plasma chloride (p < 0.0001) and fetal venous pressure (p < 0.05). The changes in urine flow rate and fetal arterial pressure were positively correlated (r = 0.46, p < 0.01), suggesting that the diuresis was mediated in part by fetal arterial pressure. The four-quadrant amniotic fluid index increased during the furosemide infusions but not during vehicle infusions (p = 0.022).
CONCLUSIONS: Furosemide infusion caused a marked dose-dependent diuresis in the ovine fetus that appears to be partly mediated by increases in vascular pressure. Although amniotic fluid volume increases and fetal blood volume decreases, the reduction in blood volume was small compared with the urine volume excreted.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8420337     DOI: 10.1016/s0002-9378(12)90923-0

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  1 in total

1.  Reversible acute fetal renal failure due to maternal exposure to angiotensin receptor blocker.

Authors:  Claudio Celentano; Federico Prefumo; Elena di Vera; Annamaria Iannicco; Davide Pio Gallo; Marco Liberati
Journal:  Pediatr Nephrol       Date:  2007-09-26       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.